Tuesday, July 12, 2016

Velpatasvir/Sofosbuvir Makes HCV Treatment Simpler, Especially for Genotypes 2 and 3

The recently approved velpatasvir/sofosbuvir once-daily pill cured HCV in 95% to 99% of those treated. In the latest HIV and ID Observations blog post, Dr. Paul Sax explains the “potentially” good news about the new treatment's cost.

No comments:

Post a Comment